Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ohno

Showing results (271-280 of 400) with videos related to

Pageof 40
Sort By:
Oncology|January 1, 1991
Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphateR Ohno, N Tatsumi, M Hirano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1984
[Treatment of adult acute promyelocytic leukemia during the period of 1974-1982]K Kawashima, E Nagura, Y Kato, et al.
Japanese Journal of Cancer Research : Gann|December 1, 1985
Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemiaY Morishima, H Sao, R Ueda, et al.
Leukemia|January 1, 1992
Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG)R Ohno, T Kobayashi, Y Morishima, et al.
The Japanese Journal of Antibiotics|March 1, 1986
[Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders]N Minami, N Uno, S Shirakawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival lengthR Ohno, Y Kato, E Nagura, et al.
Leukemia|September 1, 1995
Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)H Fukutani, T Naoe, R Ohno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1983
[Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma]H Takeyama, K Yano, T Kataoka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1983
[Clinical analysis of adult acute leukemia without successful induction of remission]K Kawashima, E Nagura, E Watanabe, et al.
Japanese Journal of Clinical Oncology|August 1, 1991
Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex)H Fukutani, T Naoe, H Saito, et al.
Pageof 40

Showing results (271-280 of 400) with videos related to

Sort By:
Pageof 40
Oncology|January 1, 1991
Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphateR Ohno, N Tatsumi, M Hirano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1984
[Treatment of adult acute promyelocytic leukemia during the period of 1974-1982]K Kawashima, E Nagura, Y Kato, et al.
Japanese Journal of Cancer Research : Gann|December 1, 1985
Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemiaY Morishima, H Sao, R Ueda, et al.
Leukemia|January 1, 1992
Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG)R Ohno, T Kobayashi, Y Morishima, et al.
The Japanese Journal of Antibiotics|March 1, 1986
[Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders]N Minami, N Uno, S Shirakawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival lengthR Ohno, Y Kato, E Nagura, et al.
Leukemia|September 1, 1995
Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)H Fukutani, T Naoe, R Ohno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1983
[Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma]H Takeyama, K Yano, T Kataoka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1983
[Clinical analysis of adult acute leukemia without successful induction of remission]K Kawashima, E Nagura, E Watanabe, et al.
Japanese Journal of Clinical Oncology|August 1, 1991
Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex)H Fukutani, T Naoe, H Saito, et al.
Pageof 40